According to the latest data from the Stock Exchange of Hong Kong, JPMorgan Chase & Co. increased its holding in Tigermed (03347) by approximately 566,578 shares on July 17th.
The transaction was executed at an average price of around HK$36.84 per share, involving a total consideration of approximately HK$20.87 million.
Following this acquisition, JPMorgan's total shareholding in the company has risen to roughly 21.34 million shares.
This represents a stake of about 17.32% in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments